Ensayos Clínicos

Multicenter, Double-Blind, Randomized, Parallel-Group Study to Assess the Efficacy and Safety of MYL-1402O Compared with Avastin, in the First-line Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer